Recombinant Human IL25 Protein, MYC/DDK-tagged

Cat.No. : IL25-1926H
Product Overview : Recombinant human IL25 protein, fused to MYC/DDK-tagged at C-terminus, was expressed in HEK293
  • Specification
  • Gene Information
  • Related Products
Description : The protein encoded by this gene is a cytokine that shares sequence similarity with interleukin 17. This cytokine can induce NF-kappaB activation, and stimulate the production of interleukin 8. Both this cytokine and interleukin 17B are ligands for the cytokine receptor IL17BR. Studies of a similar gene in mice suggest that this cytokine may be a pro-inflammatory cytokine favoring the Th2-type immune response. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010].
Source : HEK293
Species : Human
Tag : MYC/DDK
Form : 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol.
Molecular Mass : 16.7 kDa
Purity : > 80% as determined by SDS-PAGE and Coomassie blue staining
Concentration : >50 ug/mL as determined by microplate BCA method
Gene Name : IL25 interleukin 25 [ Homo sapiens ]
Official Symbol : IL25
Synonyms : IL17E; IL17E
Gene ID : 64806
mRNA Refseq : NM_022789
Protein Refseq : NP_073626
MIM : 605658
UniProt ID : Q9H293

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Q&As
  • Reviews

Q&As (6)

Ask a question
Is there any research showing that IL-25 is effective in tumor treatment? 12/10/2022

There is a lack of conclusive evidence that IL-25 has a clear effect in tumor treatment, but there are some studies underway.

Are there any side effects to IL-25? 09/22/2021

There are no clear studies on the side effects of IL-25, but the patient response needs to be closely monitored during research and clinical application.

Has the study found potential applications of IL-25 in the treatment of other diseases? 01/18/2021

In addition to treating asthma and inflammatory bowel disease, IL-25 may also have potential applications in the treatment of lung infections, urticaria and other diseases.

What is the mechanism of action of IL-25? 12/18/2020

IL-25 activates specific signaling pathways by binding to specific receptors, thereby regulating the activity of immune cells and the degree of inflammation in the body.

Is there any research showing that IL-25 is effective against certain diseases? 08/17/2020

Some studies have shown that recombinant IL-25 can improve symptoms of diseases such as asthma and inflammatory bowel disease, but more research is needed to verify its efficacy.

Does IL-25 therapy need to be administered by injection? 03/28/2019

Yes, in general, IL-25 therapy needs to be administered by injection to ensure that the protein can enter the body and work.

Customer Reviews (3)

Write a review
Reviews
01/29/2021

    Efficacy of the protein can be evaluated by observing its pharmacokinetics, pharmacodynamics and toxicity in mice or rats. -

    08/31/2019

      Animal models were used to evaluate the efficacy and side effects of the remade proteins. -

      01/05/2019

        Storage is stable, and the environmental requirements are not harsh. -

        Ask a Question for All IL25 Products

        Required fields are marked with *

        My Review for All IL25 Products

        Required fields are marked with *

        0

        Inquiry Basket

        cartIcon
        logo

        Stay Updated on the
        Latest Bioscience Trends

        Copyright © 2023 Creative BioMart. All Rights Reserved.

        Terms and Conditions        Privacy Policy